UY26965A1 - USE OF ANTIPROGESTINES FOR PROFILAXIS AND TREATMENT OF HORMONE DEPENDENT DISEASES - Google Patents

USE OF ANTIPROGESTINES FOR PROFILAXIS AND TREATMENT OF HORMONE DEPENDENT DISEASES

Info

Publication number
UY26965A1
UY26965A1 UY26965A UY26965A UY26965A1 UY 26965 A1 UY26965 A1 UY 26965A1 UY 26965 A UY26965 A UY 26965A UY 26965 A UY26965 A UY 26965A UY 26965 A1 UY26965 A1 UY 26965A1
Authority
UY
Uruguay
Prior art keywords
dependent diseases
antiprogestines
profilaxis
treatment
hormone dependent
Prior art date
Application number
UY26965A
Other languages
Spanish (es)
Inventor
Jens Hoffmann
Rosemarie Lichtner
Gerd Siemeister
Martin R Schneider
Ulrike Fuhrmann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of UY26965A1 publication Critical patent/UY26965A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Métodos y usos para prevenir o tratar enfermedades dependientes de hormonas, en particular cáncer de mama, en un mamífero mediante antiprogestinas, en particular la antiprogestina 11 beta-(4-acetilfenil)-17 beta-hidroxi-17alfa-(1,1,2,2,2-pentafluoroetil)-estra-4,9-dien-3-ona o un derivado o análogo de la misma aceptable además con composiciones farmacéuticas que comprenden dicha antiprogestina.Methods and uses to prevent or treat hormone-dependent diseases, in particular breast cancer, in a mammal by means of antiprogestins, in particular antiprogestin 11 beta- (4-acetylphenyl) -17 beta-hydroxy-17alpha- (1,1,2 , 2,2-pentafluoroethyl) -estra-4,9-diene-3-one or a derivative or analog thereof acceptable in addition to pharmaceutical compositions comprising said antiprogestin.

UY26965A 2000-10-18 2001-10-12 USE OF ANTIPROGESTINES FOR PROFILAXIS AND TREATMENT OF HORMONE DEPENDENT DISEASES UY26965A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00250341 2000-10-18

Publications (1)

Publication Number Publication Date
UY26965A1 true UY26965A1 (en) 2002-06-20

Family

ID=34072454

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26965A UY26965A1 (en) 2000-10-18 2001-10-12 USE OF ANTIPROGESTINES FOR PROFILAXIS AND TREATMENT OF HORMONE DEPENDENT DISEASES

Country Status (8)

Country Link
AR (1) AR032371A1 (en)
EA (1) EA007529B1 (en)
EC (1) ECSP034605A (en)
PE (1) PE20020520A1 (en)
RS (1) RS50389B (en)
UA (1) UA75615C2 (en)
UY (1) UY26965A1 (en)
ZA (1) ZA200303793B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19706061A1 (en) * 1997-02-07 1998-08-13 Schering Ag Anti-gestagen effective steroids with fluorinated 17alpha alkyl chain

Also Published As

Publication number Publication date
UA75615C2 (en) 2006-05-15
ECSP034605A (en) 2003-06-25
YU30103A (en) 2006-08-17
PE20020520A1 (en) 2002-06-15
EA007529B1 (en) 2006-10-27
EA200300480A1 (en) 2003-10-30
AR032371A1 (en) 2003-11-05
RS50389B (en) 2009-12-31
ZA200303793B (en) 2004-08-16

Similar Documents

Publication Publication Date Title
CY1104981T1 (en) USE OF ANTI-PROGESTONES FOR THE PREVENTION AND TREATMENT OF HORMONE DEPENDENT DISEASES
EA200600964A1 (en) PHARMACEUTICAL PREPARATION FOR CONTINUOUS HORMONAL TREATMENT DURING A LONGER LONGER THAN 21-4 DAYS, INCLUDING TWO ESTROGEN AND / OR PROGESTINE COMPOSITIONS
BRPI0416700A (en) methods for treating obesity, achieving desirable weight loss, avoiding undesirable weight gain, and facilitating weight loss in a non-depressed individual, methods of maintaining a stable weight and reducing body weight in an individual pharmaceutical composition and kit
PT912185E (en) NEW PHARMACEUTICAL FORMULATIONS CONTAINING ESTER NITRATE DERIVATIVES FROM PROVIDED ESTEROIDS AS ANTI-INFLAMMATORY DRUGS
PT1293210E (en) DEVICE AND HORMONAL ANTICONCEPTIONAL METHOD
UY26965A1 (en) USE OF ANTIPROGESTINES FOR PROFILAXIS AND TREATMENT OF HORMONE DEPENDENT DISEASES
AR044450A1 (en) COMPOSITION THAT INCLUDES ANTAGONISTS OF PROGESTERONE RECEPTORS AND PURE ANTIESTROGENS FOR THE PROPHYLAXIS AND TREATMENT OF HORMONE DEPENDENT DISEASES
EE200300157A (en) Use of antiprogestins to induce apoptosis in a cell
UY26966A1 (en) USE OF ANTIPROGESTINES FOR THE INDUCTION OF APOPTOSIS IN A CELL
TW200733955A (en) Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases
UY27301A1 (en) USE AND COMPOSITIONS OF ANTIPROGESTINES FOR THE TREATMENT OF PROSTATE DISEASES
DE602006018471D1 (en) 17-ALPHA-SUBSTITUTED DERIVATIVES OF OSTRADIOL WITH WOUND HEALING EFFECT
TH58099B (en) Antiprogestin Uses and Mixes in the Treatment of Prostate Diseases

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20141104